COAGULATION DEFECTS IN NEONATES DURING CARDIOPULMONARY BYPASS

被引:159
作者
KERN, FH
MORANA, NJ
SEARS, JJ
HICKEY, PR
机构
[1] CHILDRENS HOSP MED CTR,DEPT ANESTHESIOL,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,BOSTON,MA 02115
关键词
D O I
10.1016/0003-4975(92)90451-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined components of the coagulation system in 30 neonates (age, 1 to 30 days) undergoing deep hypothermic cardiopulmonary bypass (CPB). A coagulation profile consisting of activated clotting time; prothrombin time; partial thromboplastin time; factors II, V, VII, VIII, IX, X, and I (fibrinogen); antithrombin III; platelet count; and heparin levels was evaluated before bypass, at three intervals during bypass (1 minute after initiation of bypass, stable hypothermic CPB, warm CPB), after weaning from CPB and administration of protamine, and 2 to 3 hours after skin closure. The initiation of CPB resulted in a 50% decrease in circulating coagulation factors and antithrombin III levels. Platelet counts were reduced by 70% with CPB initiation. Neither deep hypothermic temperatures nor prolonged exposure to extracorporeal surfaces had any additional effect on the coagulation profiles. This suggests that the coagulation system of a neonate undergoing CPB is profoundly and globally effected by hemodilution. We believe that treatment of post-CPB coagulopathy in neonates must address these global deficits.
引用
收藏
页码:541 / 546
页数:6
相关论文
共 22 条
[1]  
ANDREW M, 1974, BLOOD, V75, P275
[2]  
BACHMANN F, 1975, J THORAC CARDIOV SUR, V70, P76
[3]   ANTITHROMBIN-III AND HEPARIN [J].
BARROWCLIFFE, TW ;
JOHNSON, EA ;
THOMAS, D .
BRITISH MEDICAL BULLETIN, 1978, 34 (02) :143-150
[4]  
BULL BS, 1975, J THORAC CARDIOV SUR, V69, P674
[5]  
COHEN J A, 1986, Perfusion (London), V1, P271, DOI 10.1177/026765918600100406
[6]  
EKERT H, 1968, LANCET, V2, P280
[7]  
GREELEY WJ, 1988, ANESTH ANALG, V67, P86
[8]  
GREELEY WJ, 1990, ANESTHESIA, P153
[9]  
GROSS S, 1968, PEDIATRICS, V42, P651
[10]  
HARKER LA, 1980, BLOOD, V56, P824